A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

August 14, 2009

First Generic Atripla Approved for Developing Nations

The first generic version of the fixed-dose combination tablet Atripla (tenofovir, emtricitabine and efavirenz) has been granted tentative approval by the Food and Drug Administration for use in resource-poor countries where the President’s Emergency Plan for AIDS Relief (PEPFAR) is scaling up access to antiretroviral (ARV) therapy.

Tentative approval means that the generic tablet is chemically equivalent with the safe and effective brand-name version and that its developer, Matrix Laboratories Limited of Hyderabad, India, has good standards in manufacturing.

Tentative approval is granted in order for a generic drug to be sold to programs participating in PEPFAR; it will not be sold in the United States or most other industrialized nations. This is because the patents that protect brand-name Atripla will not expire before 2017 and are still held in countries not included in the PEPFAR program.

Though generic versions of other HIV drugs have been granted tentative approval by the FDA, this is the first version of Atripla—a preferred treatment combination recommended by the U.S. Department of Health and Human Services—to be given the green light. The new generic will likely expand treatment choices for people in developing countries, where options are often limited.

Search: Atripla, generic, efavirenz, teneofivr, emtricitabine, patent, developing world, FDA, PEPFAR


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 9 (of 9 total)    

pelo, pretoria, 2011-05-06 08:06:39
As a south african citizen i wonder when is atripla going to be available in south Africa.Having once a day pill is better can the government please fast forward the the process of making this pill available since the generic form of the pill was granted approval by the FDA.

Barbara Williams, Galveston, TX, 2010-07-02 13:23:50
This is abominable. I am a caseworker at an HIV/AIDS services agency. I know of a gentleman who works hard and makes a decent living, but cannot afford $1800.00 a month for Atripla. His insurance capped his co pay without even telling him. Everywhere I have applied to in his behalf have denied him. I am at my wit's end.

Alan G, Washington,DC, 2009-12-08 13:56:25
It is so sad not to have generic available for Americans why they suffer and have pain to deal to get a simple cure medication called Atripla in Generic version, I believe for the sake of POZ people Obama administration should work on very hard to make this medication available in that price range max 300 monthly to Any American no matter they got insuarance or do not god sake this is a matter of life and death, what are they waiting for, more profits to Pharma companies....Ridicoulous...

James, Akron, 2009-08-19 16:51:46
Well isn't that just wonderful. Now, I understand that the poor countries need to have access to these meds, but there are plenty of people here in the U.S. and other industrialized nations that have a need for these types of programs and generic drugs. I think this country needs to start worrying about our own before we start worrying about others and their problems.

vk, tacoma, 2009-08-19 13:08:13
While it is great that they have developed a generic for Atripla that will be distributed in developing countries, where options are limited and so are one's finances. i just wish it would be able to be distributed in the States way earlier than 2017. I know we are supposed to be a progressive country and all, but come one $1800 a month for one med is crazy. I know many in the States that cannot afford that and don't have the option to get state help.

Dr Teddy, SFO, 2009-08-18 15:05:28
Mind you people without these trade laws, the generic version wouldn be available at all for any body. So instead of people in AFrica dying from lack of drugs and instead of the PEPFAR( which is tax payers money ofcourse )being used for Branded drugs, for a cost at least 10 times higher it is used to treat more people with a different drug( may not even be same quality but just good enough for saving poor Africans)AIDS drugs are paid by insurance in USA,if already paidfor it betteruse branded

mike, , 2009-08-18 14:31:49
Usual crap...US is part of the globe too. By the way the price for Atripla in Canada is supposed to be 60% less than we are subjected to

GJG, Atlanta, GA, 2009-08-18 11:53:21
This is so damned typical. I am so sick and tired of pharmaceutical companies making a profit due to my misfortune. Greedy bastards.

GKJ, Chickasha, 2009-08-15 05:34:22
So because I happen to be an an american citizen, I am denied access to a generic form of atripla because of greed of the drug companies.

comments 1 - 9 (of 9 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dulce_angelita
    Bronx
    New York


    Hillcrester
    Ramona
    California


    FoxyFresh57
    Bronx
    New York


    daino1972
    Columbus
    Ohio
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.